Stockreport

Generex Biotechnology Announces Date for Rescheduled May 15th Investor Conference Call to Present Organizational Roadmap & Update on Investor Dividend, Product Launch, New Acquisitions, Fi...

GENEREX BIOTECHNOLOGY  (GNBT) 
US:NASDAQ Investor Relations: generex.com/investor
PDF Generex shareholder dividend follow-upLaunch of FDA Cleared Excellagen® for Wound Management by subsidiary Olaregen TherapeutixUpdate on NuGenerex Immuno-Oncology Spin-o [Read more]